Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register

OBJECTIVES: To describe the baseline characteristics of SLE patients requiring biologic therapy in the UK and to explore short term efficacy and infection rates associated with rituximab (RTX) use. METHODS: Patients commencing biologic therapy for refractory SLE and who consented to join BILAG-BR we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatology (Oxford)
Main Authors: McCarthy, Eoghan M, Sutton, Emily, Nesbit, Stephanie, White, James, Parker, Ben, Jayne, David, Griffiths, Bridget, Isenberg, David A, Rahman, Anisur, Gordon, Caroline, D'Cruz, David P, Rhodes, Benjamin, Lanyon, Peter, Vital, Edward M, Yee, Chee-Seng, Edwards, Christopher J, Teh, Lee-Suan, Akil, Mohammed, McHugh, Neil J, Zoma, Asad, Bruce, Ian N
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850287/
https://ncbi.nlm.nih.gov/pubmed/29216396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex395
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados